Get started
Author

Hiroshi Numao

Observed names: H. Numao, H., Numao
ORCID: 0000-0002-6476-7038
Observed ORCID: 0000-0002-6476-7038
OpenAlex ID: A5006068899
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy
2022 · Hidekatsu Kuroda, Takayoshi Oikawa, et al. · Liver Cancer · 47
Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma
2014 · Shoji Kubo, Masahiko Kinoshita, et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 44
Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan
2022 · Masashi Fujita, Kazumichi Abe, et al. · Scientific Reports · 20
PDF
The utility of two-dimensional real-time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis C virus infection
2020 · Hiroshi Numao, Koji Shimaya, et al. · European Journal of Gastroenterology & Hepatology · 11
A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stage
2023 · Masashi Ninomiya, Mio Tsuruoka, et al. · Scientific Reports · 8
PDF
Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection
2022 · Akio Miyasaka, Yuichi Yoshida, et al. · Health Science Reports · 6
PDF
Telaprevir-induced acute kidney injury during treatment of chronic hepatitis C
2013 · Hidezumi Kikuchi, Hiroshi Numao · European Journal of Gastroenterology & Hepatology · 6
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues
2025 · Jun Inoue, Shinichiro Minami, et al. · Journal of Viral Hepatitis · 4
Relapsed refractory immune checkpoint inhibitor-induced colitis treated with tacrolimus and maintained with vedolizumab
2025 · Shohei Igarashi, Koji Shimaya, et al. · Clinical Journal of Gastroenterology · 3
[Hepatocellular carcinoma developing autoimmune hemolytic anemia after atezolizumab and bevacizumab combination therapy, transitioning to second-line treatment following improvement:a case report].
2025 · Masayoshi Ko, Kota Fujimaki, et al. · PubMed · 2
[Gastric varices treated by balloon-occluded retrograde transvenous obliteration following oxaliplatin-based chemotherapy for gastric cancer].
2023 · Shohei Igarashi, Masaki Munakata, et al. · PubMed · 2
A Case of Nonalcoholic Steatohepatitis in a Cured Acromegalic Patient With Severe Growth Hormone Deficiency
2015 · Satoshi Yamagata, Kazunori Kageyama, et al. · AACE Clinical Case Reports · 2
Lipodystrophy Caused by Repetitive Pegylated Interferon Injection
2013 · Hiroshi Numao, Masayuki Baba · Internal Medicine · 2
PDF
Delayed and multisystem immune-related adverse events in MSI-high colon cancer treated with nivolumab plus ipilimumab
2026 · Takato Maeda, Masaki Munakata, et al. · Clinical Journal of Gastroenterology · 1
PDF
Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen
2025 · Yudai Fujiwara, Hidekatsu Kuroda, et al. · Cancers · 1
PDF
Baseline Host Biomarkers and Six-Month Sustained Drug-Free Status After Atezolizumab–Bevacizumab for Hepatocellular Carcinoma: Exploratory Clinical Stratification Using PAN-DF Score
2026 · Chikara Iino, Tamami Abe, et al. · Cancers
Atezolizumab Plus Bevacizumab Treatment for Patients With Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer B2 Stage
2026 · Keishi Ouchi, Masashi Ninomiya, et al. · Journal of Gastroenterology and Hepatology
PDF
Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
2026 · Goki Suda, Takuya Sho, et al. · JHEP Reports
Supplemental Material for: Baseline Predictors, Prognostic Impact, and Risk Stratification of Early Progressive Disease on Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study
2026 · figshare admin karger, Takuya Sho, et al. · Figshare
Baseline Predictors, Prognostic Impact, and Risk Stratification of Early Progressive Disease on Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study
2026 · Takuya Sho, Goki Suda, et al. · Liver Cancer
PDF
Supplementary Material for: Sequential pancreatic ascites and hemosuccus pancreaticus from an identical rupture site in branch-duct IPMN: A Case Report
2026 · karger, figshare admin, S., Sasakura, et al. · Figshare
Sequential Pancreatic Ascites and Hemosuccus Pancreaticus from an Identical Rupture Site in Branch-Duct Intraductal Papillary Mucinous Neoplasm: A Case Report
2026 · Seiya Sasakura, Masayoshi Ko, et al. · Case Reports in Gastroenterology
PDF
A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage
2025 · Masashi Ninomiya, Mio Tsuruoka, et al. · Cancer Medicine
PDF
Successful Colonic Stenting Across the Ileocecal Valve With Severe Malignant Stenosis Using Ultra‐thin Scope and Single‐balloon Overtube
2025 · Takato Maeda, Norihiro Hanabata, et al. · DEN Open
PDF
Morphological change of foveolar‐type gastric adenocarcinoma after proton pump inhibitor discontinuation in a short time period: A case report
2023 · Shohei Igarashi, Norihiro Hanabata, et al. · DEN Open
PDF
Works count: 28
Citation count: 159
H-index: 6
I10-index: 4
Year
Topic
Type